Author

Sonia Paget

Centre de Recherches en Cancérologie de LilleORCID 0000-0003-2524-6034Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:clustering· 1 Research Focus:development & morphogenesis· 1 Assay:DNA methylation· 1

Frequent Co-Authors

Jean‐Pascal MenebooiD· 2 shared Martin FigeaciD· 2 shared Agathe LaratteiD· 1 shared Alexis Benjamin CortotiD· 1 shared Andréa ParadisiiD· 1 shared Anne Chotteau‐LelièvreiD· 1 shared Audrey VincentiD· 1 shared Audrey VinchentiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Jean‐Pascal MenebooORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyiSciencePeer-reviewedNov 29, 2025

Long non-coding RNA UCA1 affects chromatin remodeling via SMARCA2-containing SWI/SNF complex in human colorectal cancer.

Bernadette Neve, Elsa Hadj Bachir, Bélinda Duchêne…·Nicolas Jonckheere

This study shows that lncRNA UCA1 influences chromatin remodeling via the SWI/SNF complex in colorectal cancer, affecting stem-cell properties and drug response.

3 citations

humanDNA methylation

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 10, 2025

Oncogenic mutations convert MET from a pro-apoptotic tumor suppressor to an oncogenic driver

Rémi Tellier, Marie Fernandes, Audrey Vinchent…·David Tulasne

The paper shows that MET exon 14 skipping mutations eliminate the pro-apoptotic function of MET, converting it from a tumor suppressor to an oncogenic driver in lung adenocarcinomas.

DOI 10.1101/2025.11.10.687614

mouseexperimental assay

𝕏 PostBluesky